For research use only. Not for therapeutic Use.
Ancitabine hydrochloride (Cat No.:I000151) , also known as 1-beta-D-arabinofuranosylcytosine hydrochloride or cytarabine hydrochloride, is an important antileukemia drug. It belongs to the class of nucleoside analogs and is commonly used in the treatment of acute myeloid leukemia (AML) and other hematological malignancies. Ancitabine is converted into its active form inside the cells, where it inhibits DNA synthesis and induces cell death in rapidly dividing cancer cells.
| Catalog Number | I000151 |
| CAS Number | 10212-25-6 |
| Molecular Formula | C9H12ClN3O4 |
| Purity | ≥95% |
| Target | Anti-infection |
| Solubility | 10 mM in DMSO |
| Storage | 2-8°C |
| IUPAC Name | (2R,4R,5R,6S)-4-(hydroxymethyl)-10-imino-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-5-ol;hydrochloride |
| InChI | InChI=1S/C9H11N3O4.ClH/c10-5-1-2-12-8-7(16-9(12)11-5)6(14)4(3-13)15-8;/h1-2,4,6-8,10,13-14H,3H2;1H/t4-,6-,7+,8-;/m1./s1 |
| InChIKey | KZOWNALBTMILAP-JBMRGDGGSA-N |
| SMILES | C1=CN2C3C(C(C(O3)CO)O)OC2=NC1=N.Cl |
